New analysis in The Lancet Public Health reveals rising exposure rates in sub-Saharan Africa and the Middle East, contrasting with declines in wealthy nations.
Second-hand smoke exposure in sub-Saharan Africa nearly doubled between 1990 and 2023, contrasting with sharp declines in high-income countries, according to a study published in The Lancet Public Health.
AI-generated summary
The Lancet Public Health published an analysis examining second-hand smoke exposure across 204 countries and territories from 1990 to 2023.
The number of people exposed to second-hand smoke in sub-Saharan Africa has nearly doubled since 1990, in contrast to significant progress in reducing exposure in high income countries.
The region saw the largest increase anywhere in the world, with the number of people exposed rising by 98.5 per cent between 1990 and 2023.
Second-hand smoke was also linked to an estimated 84,000 deaths in the region in 2023 and 3.9 million years of healthy life lost, as well as 1.66 million deaths globally.
The analysis, published in The Lancet Public Health journal looked at second-hand smoke exposure across 204 countries and territories over more than three decades.
Exposure has fallen sharply in wealthier countries, as smoking rates have declined and smoke-free laws have become more widespread. The proportion of people exposed fell by about a third between 1990 and 2023.
In contrast, some 234 million people in sub-Saharan Africa were exposed in 2023, up from 118 million three decades earlier.
The Middle East and North Africa also saw a large increase at over 72 per cent. Qatar saw the largest increase in the absolute number of people exposed, at a huge 558.9 per cent, with the United Arab Emirates at 343.1 per cent.
The report, the Global Burden of Disease Study, does not give a detailed analysis of whether this meant more people were smoking. In many regions, the proportion of people exposed to second-hand smoke has declined since 1990, but population growth means more people are exposed.
However, the exposure does broadly mirror patterns of active smoking, with many low- and middle-income countries still seeing persistently high numbers of smokers.
Second-hand smoke is smoke inhaled by people who are near someone using tobacco products. The leading cause of death associated with adult exposure to it was Ischemic heart disease, according to the report, with 5.2 million years of healthy life lost to lower respiratory infections.
Globally, the proportion of people exposed to second-hand smoke has fallen substantially since 1990, but 2.7 billion people were still exposed in 2023, including 767 million children.
High-income countries have made significant gains, with countries such as Denmark and Norway seeing the proportion of people exposed to second-hand smoke fall by almost half since 1990. Canada also fell by 40 per cent, with Latin America and the Caribbean also seeing a steep decline.
The report said second-hand smoke remains a major global health risk and called for stronger tobacco-control measures to protect people, particularly women and children.

New research reveals prenatal Tylenol exposure may influence female reproductive organ development in infants, showing smaller ovaries and fewer follicles, though long-term fertility impacts remain unproven.

A study of over 300 mothers and babies in Cape Town found that infants born to mothers with anaemia had 4% lower total brain volume at birth, with differences in key regions linked to movement, learning and emotion regulation widening to 6% by age two, suggesting lasting cognitive impacts.

Sudan's healthcare system faces a deep crisis as international aid funding dwindles, cutting millions off from essential services, Doctors Without Borders warns.

While popular GLP-1 weight-loss drugs like Ozempic and Wegovy help many lose significant weight, a small proportion of patients experience little effect. Researchers are now exploring genetic, hormonal, and demographic factors behind this non-response.

Tens of thousands of NHS patients have withdrawn their data from research projects, prompting concern from Health Innovation Minister James Frith about mistrust in Palantir and its impact on data sharing. The government is reviewing Palantir's £330m contract to operate the NHS federated data platform, amid criticism over the company's ties to the Israeli military and Trump's ICE agency. While Palantir claims its AI technology has improved NHS performance, NHS England and the UK statistics watchdog say causation cannot be proven. Frith confirmed a policy shift, stating NHS trusts are no longer required to use the platform and may prefer alternatives.

Mirsal Adel, a 47-year-old father from Ibb, Yemen, traveled 75km to Taiz to vaccinate his four-month-old son after UNICEF halted operations in Houthi-controlled areas in October 2025, leaving nearly five million children without access to routine immunizations amid ongoing conflict and bureaucratic obstruction between rival health ministries.